Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $6,310 - $7,055
-109 Reduced 2.8%
3,778 $219,000
Q2 2023

Sep 07, 2023

SELL
$63.71 - $70.74 $49,502 - $54,964
-777 Reduced 16.66%
3,887 $248,000
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $49,502 - $54,964
-777 Reduced 16.66%
3,887 $248,000
Q1 2023

Sep 07, 2023

BUY
$65.71 - $74.53 $46,062 - $52,245
701 Added 17.69%
4,664 $323,000
Q1 2023

Sep 01, 2023

BUY
$65.71 - $74.53 $46,062 - $52,245
701 Added 17.69%
4,664 $323,000
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $50,005 - $56,717
761 Added 19.5%
4,664 $323,000
Q4 2022

Sep 07, 2023

BUY
$68.48 - $81.09 $5,204 - $6,162
76 Added 1.96%
3,963 $285,000
Q4 2022

Sep 01, 2023

BUY
$68.48 - $81.09 $5,204 - $6,162
76 Added 1.96%
3,963 $285,000
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $63,138 - $74,764
-922 Reduced 19.11%
3,903 $280,000
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $17 - $10,450
-136 Reduced 2.74%
4,825 $343,000
Q2 2022

Aug 01, 2022

BUY
$72.62 - $79.98 $107,114 - $117,970
1,475 Added 42.31%
4,961 $382,000
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $34,121 - $40,914
-555 Reduced 13.73%
3,486 $220,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $4,129 - $4,814
77 Added 1.94%
4,041 $252,000
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $37,099 - $43,457
627 Added 18.79%
3,964 $235,000
Q2 2021

Jul 23, 2021

SELL
$61.91 - $67.42 $9,224 - $10,045
-149 Reduced 4.27%
3,337 $223,000
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $185,022 - $208,095
-3,118 Reduced 47.21%
3,486 $220,000
Q4 2020

Feb 01, 2021

SELL
$57.74 - $65.43 $2.32 Million - $2.63 Million
-40,159 Reduced 85.88%
6,604 $410,000
Q3 2020

Oct 21, 2020

SELL
$57.43 - $63.64 $15 Million - $16.6 Million
-261,463 Reduced 84.83%
46,763 $2.82 Million
Q2 2020

Jul 23, 2020

BUY
$54.82 - $64.09 $8.72 Million - $10.2 Million
159,141 Added 106.75%
308,226 $18.1 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $6.73 Million - $9.77 Million
144,956 Added 3510.68%
149,085 $8.31 Million
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $38,383 - $50,068
-780 Reduced 15.89%
4,129 $265,000
Q3 2019

Oct 24, 2019

SELL
$42.77 - $50.71 $254,738 - $302,028
-5,956 Reduced 54.82%
4,909 $249,000
Q2 2019

Jul 22, 2019

BUY
$44.62 - $49.34 $484,796 - $536,079
10,865 New
10,865 $493,000
Q4 2017

Jan 23, 2018

SELL
$59.94 - $65.35 $848,750 - $925,355
-14,160 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$55.23 - $63.74 $782,056 - $902,558
14,160
14,160 $903,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jag Capital Management, LLC Portfolio

Follow Jag Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jag Capital Management, LLC with notifications on news.